John Pollack, MD, discusses gene therapy advancements in the first installment of his blog for Modern Retina.
John Pollack, MD
Advertisement
John Pollack, MD, practices at Illinois Retina Associates and is an assistant professor of ophthalmology at Rush University Medical Center in Chicago. Dr. Pollack is also Chief Medical Officer at Neurotech and past President of the American Society of Retina Specialists.
Articles by John Pollack, MD
With orphan drug and fast track status, Neurotech plans to seek FDA approval for its NT-501 Implant platform late next year.
Advertisement
Latest Updated Articles
What is encapsulated cell therapy?Published: September 22nd 2021 | Updated:
Advertisement
Advertisement
